Teva Pharmaceutical reported 832M in Selling and Administration Expenses for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Aspen Pharmacare APN:SJ 4.61B 120M
Cipla CIPLA:IN 8.87B 725.7M
Dr.Reddys Laboratories DRRD:IN 23.25B 1.53B
Guangzhou Baiy 600332:CH 1.67B 661.45M
Jiangsu Hengrui Me. 600276:CH 2.7B 181.85M
Kalbe Farma Tbk Pt KLBF:IJ 1475.05B 50.14B
Richter Gedeon RICHT:HB 35.1B 1.39B
Sh Fosun Pharma 600196:CH 3.02B 209.5M
Sun Pharmaceuticals SUNP:IN 17.59B 812.9M
Teva Pharmaceutical TEVA:IT 832M 16M